Cite

HARVARD Citation

    Sun, X. et al. (2021). Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review. Breast. pp. 26-34. [Online]. 
  
Back to record